Phosphorylation of the Twist1-family basic helix-loop-helix transcription factors is involved in pathological cardiac

Shuangshuang Lu1, Junwei Nie, Qing Luan

  • 1The Ministry of Education Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, Nanjing University, Nanjing, China.

Plos One
|May 12, 2011
PubMed

Insights

Phosphorylation of Twist1 family transcription factors by Akt signaling in cardiomyocytes drives pathological cardiac remodeling, leading to heart failure. This study reveals a novel regulatory mechanism for Twist1 in heart disease.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Transcription Factor Regulation

Background:

  • Twist1-family basic helix-loop-helix (bHLH) transcription factors are crucial for heart development.
  • Phosphorylation of these factors in the basic-helix I domain influences development, but their role in the postnatal heart is unclear.

Purpose of the Study:

  • To investigate the role of Twist1 family phosphorylation in postnatal cardiac remodeling.
  • To determine if Akt signaling regulates Twist1 family members in the heart.

Main Methods:

  • Generated transgenic mice overexpressing Hand1 and Twist1 mutants in cardiomyocytes.
  • Performed gene expression profiling and biochemical analyses.
  • Assessed transcriptional activation and DNA binding ability.

Main Results:

  • Overexpression of Hand1 and Twist1 mutants induced pathological cardiac remodeling, heart failure, and sudden death in mice.
  • Observed altered gene expression, including up-regulation of growth genes and down-regulation of metabolic genes.
  • Demonstrated direct phosphorylation of Hand1 and Twist1 by Akt in the basic-helix I domain, affecting Hand1's transcriptional activity.

Conclusions:

  • Twist1 family transcription factors are regulated by Akt signaling in the heart.
  • This regulation plays a significant role in pathological cardiac remodeling and heart failure.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...